In latest deal, Innovent seeds Spero's future beyond GSK-owned antibiotic

July 14, 2026 06:00 AM EDT FinancingDealsChina In lat­est deal, In­novent seeds Sper­o's fu­ture be­yond GSK-owned an­tibi­ot­ic Kyle LaHucik Biotech Correspondent Af­ter part­ner­ing with four of the largest phar­ma­ceu­ti­cal com­pa­nies over the past 18 months, In­novent Bi­o­log­ics is turn­ing to a small­er part­ner for its next … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER